Cargando…

Comment on Melatonin as a potential adjuvant treatment for COVID-19

Detalles Bibliográficos
Autores principales: Herrera, Emilio A., González-Candia, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192085/
https://www.ncbi.nlm.nih.gov/pubmed/32360622
http://dx.doi.org/10.1016/j.lfs.2020.117739
_version_ 1783527958265200640
author Herrera, Emilio A.
González-Candia, Alejandro
author_facet Herrera, Emilio A.
González-Candia, Alejandro
author_sort Herrera, Emilio A.
collection PubMed
description
format Online
Article
Text
id pubmed-7192085
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71920852020-04-30 Comment on Melatonin as a potential adjuvant treatment for COVID-19 Herrera, Emilio A. González-Candia, Alejandro Life Sci Commentary Elsevier Inc. 2020-07-15 2020-04-30 /pmc/articles/PMC7192085/ /pubmed/32360622 http://dx.doi.org/10.1016/j.lfs.2020.117739 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Herrera, Emilio A.
González-Candia, Alejandro
Comment on Melatonin as a potential adjuvant treatment for COVID-19
title Comment on Melatonin as a potential adjuvant treatment for COVID-19
title_full Comment on Melatonin as a potential adjuvant treatment for COVID-19
title_fullStr Comment on Melatonin as a potential adjuvant treatment for COVID-19
title_full_unstemmed Comment on Melatonin as a potential adjuvant treatment for COVID-19
title_short Comment on Melatonin as a potential adjuvant treatment for COVID-19
title_sort comment on melatonin as a potential adjuvant treatment for covid-19
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192085/
https://www.ncbi.nlm.nih.gov/pubmed/32360622
http://dx.doi.org/10.1016/j.lfs.2020.117739
work_keys_str_mv AT herreraemilioa commentonmelatoninasapotentialadjuvanttreatmentforcovid19
AT gonzalezcandiaalejandro commentonmelatoninasapotentialadjuvanttreatmentforcovid19